Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for MyMD Pharmaceuticals, Inc. (MYMD : NSDQ)
 
 • Company Description   
MyMD Pharmaceuticals Inc. is a clinical stage pharmaceutical company involved in developing therapeutic platforms. MyMD Pharmaceuticals Inc., formerly known as Akers Biosciences Inc., is based in Maryland.

Number of Employees: 4

 
 • Price / Volume Information   
Yesterday's Closing Price: $6.73 Daily Weekly Monthly
20 Day Moving Average: 226,149 shares
Shares Outstanding: 37.64 (millions)
Market Capitalization: $253.32 (millions)
Beta: 0.53
52 Week High: $10.48
52 Week Low: $3.30
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -28.44% -26.21%
12 Week -6.53% -7.46%
Year To Date 69.10% 44.74%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
855 N. WOLFE STREET SUITE 623
-
BALTIMORE,MD 21205
USA
ph: 856-848-8698
fax: 856-848-0269
investors@akersbio.com http://www.akersbio.com
 
 • General Corporate Information   
Officers
Christopher C. Schreiber - President and Chief Executive Officer
Joshua Silverman - Chairman of the Board
Ian Rhodes - Interim Chief Financial Officer
Bill J. White - Director
Robert C. Schroeder - Director

Peer Information
MyMD Pharmaceuticals, Inc. (GSAC)
MyMD Pharmaceuticals, Inc. (CASI)
MyMD Pharmaceuticals, Inc. (ALCD.)
MyMD Pharmaceuticals, Inc. (OMNN)
MyMD Pharmaceuticals, Inc. (CGPI.)
MyMD Pharmaceuticals, Inc. (ISR)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-DRUGS
Sector: Medical
CUSIP: 62856X102
SIC: 2835
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/21
Next Expected EPS Date: 02/11/22
Share - Related Items
Shares Outstanding: 37.64
Most Recent Split Date: 4.00 (0.50:1)
Beta: 0.53
Market Capitalization: $253.32 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 02/11/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 9.84
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: 80.26%
vs. Previous Quarter: 70.00%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
09/30/21 - -94.18
06/30/21 - -89.37
03/31/21 - -47.06
ROA
09/30/21 - -86.71
06/30/21 - -81.75
03/31/21 - -42.67
Current Ratio
09/30/21 - 7.62
06/30/21 - 6.68
03/31/21 - 14.45
Quick Ratio
09/30/21 - 7.62
06/30/21 - 6.68
03/31/21 - 14.45
Operating Margin
09/30/21 - -
06/30/21 - -
03/31/21 - -
Net Margin
09/30/21 - -
06/30/21 - -
03/31/21 - -
Pre-Tax Margin
09/30/21 - -
06/30/21 - -
03/31/21 - -
Book Value
09/30/21 - 0.68
06/30/21 - 0.84
03/31/21 - 4.00
Inventory Turnover
09/30/21 - -
06/30/21 - -
03/31/21 - -
Debt-to-Equity
09/30/21 - 0.00
06/30/21 - 0.00
03/31/21 - 0.00
Debt-to-Capital
09/30/21 - 0.00
06/30/21 - 0.00
03/31/21 - 0.00
 

Powered by Zacks Investment Research ©